worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Novartis Newsroom

Novartis Newsroom

Feature stories

2008

December 18, 2008

NITD: Combating neglected tropical diseases

The Novartis Institute for Tropical Diseases aims to discover novel treatments and prevention methods for major tropical diseases.

 

 


November 10, 2008

Novartis brings "diabetes to light"

The Novartis lighting ceremony demonstrates the commitment of the company in providing innovative therapies for the treatment of diabetes.

 

 


June 16, 2008

Joining forces against the new wave of tuberculosis

Once thought a disease of the past, tuberculosis is again becoming an international health threat.

 

 


April 25, 2008

Zambezi Expedition puts malaria in the spotlight

Novartis is part of a multi-agency partnership supporting an ambitious journey along the Zambezi River, highlighting the difficulty of delivering mosquito nets and malaria treatment to remote African communities.

 

 


March 19, 2008

NVGH blazes a trail: Effective and affordable vaccines for the developing world

Many eminent scientists are contributing to the Novartis Vaccines Institute for Global Health, the first research center established by a major vaccine manufacturer with a nonprofit mission - to discover and develop vaccines for “neglected” diseases of the developing world.

 

 


February 28, 2008

February 29 is Rare Disease Day in Europe

Rare diseases affect nearly 36 million people in the European Union alone. Learn more about this pioneer initiative in Europe to raise awareness of rare diseases and the Novartis commitment to address unmet needs.

 

 


January 25, 2008

International Leprosy Congress in Hyderabad

Novartis and the Novartis Foundation for Sustainable Development are working toward the elimination of leprosy. "Toward a world without leprosy" was the motto of the 17th International Leprosy Congress in Hyderabad, India.

 

Back to top

About Novartis

About Novartis

We provide medicines to treat and prevent diseases, ease suffering and improve quality of life.

Our products

Patient

We have a broad healthcare portfolio.